142 related articles for article (PubMed ID: 24966267)
1. Vincristine-induced polyneuropathy in a child with stage I Wilms' tumour presenting with unilateral abducens nerve palsy.
Panjawatanan P; Charoenkwan P; Katanyuwong K; Choeyprasert W
BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24966267
[TBL] [Abstract][Full Text] [Related]
2. Isolated abducens nerve palsy induced by vincristine therapy.
Toker E; Yenice O; Oğüt MS
J AAPOS; 2004 Feb; 8(1):69-71. PubMed ID: 14970804
[TBL] [Abstract][Full Text] [Related]
3. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
[TBL] [Abstract][Full Text] [Related]
4. Treatment of vincristine-induced cranial polyneuropathy.
Duman O; Tezcan G; Hazar V
J Pediatr Hematol Oncol; 2005 Apr; 27(4):241-2. PubMed ID: 15838404
[No Abstract] [Full Text] [Related]
5. Acute sixth-nerve palsy after vincristine therapy.
Lash SC; Williams CP; Marsh CS; Crithchley C; Hodgkins PR; Mackie EJ
J AAPOS; 2004 Feb; 8(1):67-8. PubMed ID: 14970803
[TBL] [Abstract][Full Text] [Related]
6. Vincristine induced cranial polyneuropathy.
Bay A; Yilmaz C; Yilmaz N; Oner AF
Indian J Pediatr; 2006 Jun; 73(6):531-3. PubMed ID: 16816519
[TBL] [Abstract][Full Text] [Related]
7. Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy.
Akbayram S; Akgun C; Doğan M; Sayin R; Caksen H; Oner AF
Indian J Pediatr; 2010 Jun; 77(6):681-3. PubMed ID: 20532679
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumour: adjuvant treatment with actinomycin D and vincristine.
Jenkin RD; Jeffs RD; Stephens CA; Sonley MJ
Can Med Assoc J; 1976 Jul; 115(2):136-40. PubMed ID: 179690
[TBL] [Abstract][Full Text] [Related]
9. Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature.
Ngamphaiboon N; Sweeney R; Wetzler M; Wang ES
Leuk Res; 2010 Aug; 34(8):e194-6. PubMed ID: 20167372
[No Abstract] [Full Text] [Related]
10. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
[TBL] [Abstract][Full Text] [Related]
11. Role of chest computed tomography at diagnosis in the management of Wilms' tumor: a study by the United Kingdom Children's Cancer Study Group.
Owens CM; Veys PA; Pritchard J; Levitt G; Imeson J; Dicks-Mireaux C
J Clin Oncol; 2002 Jun; 20(12):2768-73. PubMed ID: 12065552
[TBL] [Abstract][Full Text] [Related]
12. [Electrophysiological studies in vincristin-polyneuropathy (author's transl)].
Mamoli B; Heiss WD; Podreka I; Turnheim M
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1980 Mar; 11(1):21-7. PubMed ID: 6773738
[TBL] [Abstract][Full Text] [Related]
13. A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
Yau T; Leong CH; Chan WK; Chan JK; Liang RH; Epstein RJ
Cancer Chemother Pharmacol; 2008 Apr; 61(4):717-20. PubMed ID: 17571263
[TBL] [Abstract][Full Text] [Related]
14. The morbidity and outcome of surgery in children with large pre-treated Wilms' tumour: size matters.
Hadley GP; Shaik AS
Pediatr Surg Int; 2006 May; 22(5):409-12. PubMed ID: 16607520
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Wilms' tumour. Current recommendations.
Mehta MP; Bastin KT; Wiersma SR
Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
[TBL] [Abstract][Full Text] [Related]
16. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
[TBL] [Abstract][Full Text] [Related]
17. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis.
Olek MJ; Bordeaux B; Leshner RT
J Am Osteopath Assoc; 1999 Mar; 99(3):165-7. PubMed ID: 10217912
[TBL] [Abstract][Full Text] [Related]
18. Vincristine sulfate and radiation therapy in metastatic Wilms' tumor.
Vietti TJ; Sullivan MP; Haggard ME; Holcomb TM; Berry DH
Cancer; 1970 Jan; 25(1):12-20. PubMed ID: 4312025
[No Abstract] [Full Text] [Related]
19. Vincristine-induced Polyneuropathy at FDG PET/CT.
Ng KS; Leung JMS
Radiology; 2019 Oct; 293(1):36. PubMed ID: 31407973
[No Abstract] [Full Text] [Related]
20. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]